• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[不可用]。

[Not Available].

作者信息

Zerati Antonio Eduardo, Wolosker Nelson, de Luccia Nelson, Puech-Leão Pedro

机构信息

Universidade de São Paulo - USP, Faculdade de Medicina, Hospital das Clínicas, São Paulo, SP, Brasil.

出版信息

J Vasc Bras. 2017 Apr-Jun;16(2):128-139. doi: 10.1590/1677-5449.008216.

DOI:10.1590/1677-5449.008216
PMID:29930637
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5915861/
Abstract

Access to the venous system is of vital importance for diagnosis and treatment of patients with the most varied range of clinical conditions, whether for taking blood samples or for infusion of solutions. In 1616, Harvey described the circulatory system on the basis of studies in animals and 4 decades later Sir Christopher Wren conducted the first intravenous infusions in living beings. Since then there has been constant evolution in access technique and infusion devices. Of particular note is the creation of long-term catheters in the 1970s, particularly totally implantable devices, which revolutionized cancer treatment, increasing both safety and comfort for oncology patients. The objectives of this article are to review historical data on vascular access and discuss the implantation technique and the main complications associated with procedures for placement and use of totally implantable venous access devices.

摘要

无论是采集血样还是输注溶液,进入静脉系统对于患有各种临床病症的患者的诊断和治疗都至关重要。1616年,哈维基于对动物的研究描述了循环系统,40年后,克里斯托弗·雷恩爵士在活体上进行了首次静脉输注。从那时起,进入技术和输注装置不断发展。特别值得一提的是20世纪70年代长期导管的发明,尤其是完全植入式装置,它彻底改变了癌症治疗方式,提高了肿瘤患者的安全性和舒适度。本文的目的是回顾血管通路的历史数据,并讨论完全植入式静脉通路装置的植入技术以及与放置和使用程序相关的主要并发症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e7/5915861/53fdf64af572/jvb-16-02-128-g07-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e7/5915861/ba9edd4c83a3/jvb-16-02-128-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e7/5915861/7c310cd64b51/jvb-16-02-128-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e7/5915861/ba6b6b9771f1/jvb-16-02-128-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e7/5915861/252cd36b51c2/jvb-16-02-128-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e7/5915861/4295ee14bc23/jvb-16-02-128-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e7/5915861/26bb8ab65854/jvb-16-02-128-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e7/5915861/53fdf64af572/jvb-16-02-128-g07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e7/5915861/ba9edd4c83a3/jvb-16-02-128-g01-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e7/5915861/7c310cd64b51/jvb-16-02-128-g02-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e7/5915861/dc719fdf6c72/jvb-16-02-128-g03-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e7/5915861/252cd36b51c2/jvb-16-02-128-g04-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e7/5915861/4295ee14bc23/jvb-16-02-128-g05-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e7/5915861/26bb8ab65854/jvb-16-02-128-g06-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e7/5915861/53fdf64af572/jvb-16-02-128-g07-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e7/5915861/ba9edd4c83a3/jvb-16-02-128-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e7/5915861/7c310cd64b51/jvb-16-02-128-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e7/5915861/ba6b6b9771f1/jvb-16-02-128-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e7/5915861/252cd36b51c2/jvb-16-02-128-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e7/5915861/4295ee14bc23/jvb-16-02-128-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e7/5915861/26bb8ab65854/jvb-16-02-128-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e7/5915861/53fdf64af572/jvb-16-02-128-g07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e7/5915861/ba9edd4c83a3/jvb-16-02-128-g01-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e7/5915861/7c310cd64b51/jvb-16-02-128-g02-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e7/5915861/dc719fdf6c72/jvb-16-02-128-g03-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e7/5915861/252cd36b51c2/jvb-16-02-128-g04-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e7/5915861/4295ee14bc23/jvb-16-02-128-g05-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e7/5915861/26bb8ab65854/jvb-16-02-128-g06-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e7/5915861/53fdf64af572/jvb-16-02-128-g07-en.jpg

相似文献

1
[Not Available].[不可用]。
J Vasc Bras. 2017 Apr-Jun;16(2):128-139. doi: 10.1590/1677-5449.008216.

引用本文的文献

1
Analysis of the functioning of temporary dialysis catheters in patients with COVID-19.新型冠状病毒肺炎患者临时透析导管功能分析
J Vasc Bras. 2025 Jul 28;24:e20250005. doi: 10.1590/1677-5449.202500052. eCollection 2025.
2
Analysis of the reasons for removal of vascular ports in patients treated in chemotherapy and gynecological oncology departments - preliminary investigations.化疗及妇科肿瘤科室患者血管通路拔除原因分析——初步调查
Prz Menopauzalny. 2025 Jun;24(2):102-112. doi: 10.5114/pm.2025.152126. Epub 2025 Jun 16.
3
Infections in Children with Cancer Admitted in an Oncology Reference Hospital: A Cross-sectional Study.儿童癌症患者感染:一项横断面研究。
Curr Microbiol. 2023 Aug 7;80(9):315. doi: 10.1007/s00284-023-03420-y.
4
Follow up of utility and value of totally implantable chemotherapy catheter in 233 brazilian patients receiving chemotherapy to treat cancer.233 例接受化疗治疗癌症的巴西患者使用完全植入式化疗导管的实用性和价值的随访。
Rev Col Bras Cir. 2023 Jul 10;50:e20233367. doi: 10.1590/0100-6991e-20233367-en. eCollection 2023.
5
Inadequate positioning of central venous catheters inserted at intensive care units.重症监护病房中心静脉导管置入位置不当。
Einstein (Sao Paulo). 2022 Apr 8;20:eAO6497. doi: 10.31744/einstein_journal/2022AO6497. eCollection 2022.
6
Portacath Implantation in Ghana: Initial Experience at the Komfo Anokye Teaching Hospital in Kumasi.加纳的输液港植入术:库马西Komfo Anokye教学医院的初步经验。
Clin Med Insights Case Rep. 2022 Mar 22;15:11795476221087910. doi: 10.1177/11795476221087910. eCollection 2022.
7
Portocath insertion technique: retrospective study & step-by-step surgical description without tunneling in a high-complexity service.经皮 PORT 导管插入技术:在高复杂度医疗中心中无隧道技术的回顾性研究和分步手术描述
Rev Col Bras Cir. 2022 Mar 21;49:e20223167. doi: 10.1590/0100-6991e-20223167. eCollection 2022.
8
Spontaneous Knot Formation in a Central Venous Catheter.中心静脉导管内自发成结。
Am J Case Rep. 2021 Sep 15;22:e932354. doi: 10.12659/AJCR.932354.
9
Analysis of infection rates and duration of short and long-term hemodialysis catheters in a teaching hospital.教学医院短期和长期血液透析导管感染率及使用时长分析
J Vasc Bras. 2020 Sep 14;19:e20190142. doi: 10.1590/1677-5449.190142. eCollection 2020.
10
The Profile of Microorganisms Responsible for Port-Related Bacteremia in Pediatric Hemato-Oncological Patients.港口相关菌血症与儿科血液肿瘤患者的微生物特征。
Cancer Control. 2020 Jan-Dec;27(1):1073274820904696. doi: 10.1177/1073274820904696.

本文引用的文献

1
Risk factors for infectious and noninfectious complications of totally implantable venous catheters in cancer patients.癌症患者完全植入式静脉导管感染和非感染性并发症的危险因素。
J Vasc Surg Venous Lymphat Disord. 2016 Apr;4(2):200-5. doi: 10.1016/j.jvsv.2015.10.008.
2
Fracture and migration into the coronary sinus of a totally implantable catheter introduced via the right internal jugular vein.经右颈内静脉置入的完全植入式导管发生骨折并移入冠状窦。
BMJ Case Rep. 2014 Dec 1;2014:bcr2014207276. doi: 10.1136/bcr-2014-207276.
3
Complex central venous catheter insertion for hemodialysis.
用于血液透析的复杂中心静脉导管插入术。
J Vasc Access. 2014;15 Suppl 7:S136-9. doi: 10.5301/jva.5000250. Epub 2014 Apr 18.
4
Clinical guidelines on central venous catheterisation. Swedish Society of Anaesthesiology and Intensive Care Medicine.中心静脉置管临床指南。瑞典麻醉与重症监护医学学会。
Acta Anaesthesiol Scand. 2014 May;58(5):508-24. doi: 10.1111/aas.12295. Epub 2014 Mar 5.
5
Comparative study of valved and nonvalved fully implantable catheters inserted via ultrasound-guided puncture for chemotherapy.经超声引导穿刺插入的带瓣膜和不带瓣膜的全植入式导管用于化疗的对比研究。
Ann Vasc Surg. 2014 Feb;28(2):351-7. doi: 10.1016/j.avsg.2013.01.025. Epub 2013 Oct 3.
6
Infection related to implantable central venous access devices in cancer patients: epidemiology and risk factors.癌症患者与植入式中心静脉通路装置相关的感染:流行病学和危险因素。
Infect Control Hosp Epidemiol. 2013 Jul;34(7):671-7. doi: 10.1086/671006. Epub 2013 May 21.
7
Elimination of pneumothorax and hemothorax during placement of implantable venous access ports using ultrasound and fluoroscopic guidance.在超声和荧光透视引导下植入式静脉通路端口置入过程中气胸和血胸的消除。
Vascular. 2013 Dec;21(6):345–8. doi: 10.1177/1708538112472279.
8
International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer.国际临床实践指南:癌症患者中心静脉导管相关血栓形成的治疗和预防。
J Thromb Haemost. 2013 Jan;11(1):71-80. doi: 10.1111/jth.12071.
9
Venous access salvage techniques.静脉通路挽救技术。
Tech Vasc Interv Radiol. 2011 Dec;14(4):225-32. doi: 10.1053/j.tvir.2011.05.006.
10
Totally implantable venous catheters: insertion via internal jugular vein with pocket implantation in the arm is an alternative for diseased thoracic walls.
J Vasc Access. 2012 Jan-Mar;13(1):71-4. doi: 10.5301/JVA.2011.8486.